Naihui H. Chu
No 9, Beiguan Street
Tongzhou, 101149, China
Tongzhou, 101149, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Correction: Safety, tolerability, and concordance with interferon-γ release assays of a recombinant ESAT6-MPT64 skin test: a phase 1 randomized clinical trial.
Journal: Frontiers in immunology
Published: April 22, 2026
Evaluation of contezolid's cerebrospinal fluid concentration and safety in tuberculous meningitis patients.
Journal: Microbiology spectrum
Published: March 13, 2026
Increasing in vivo drug exposure levels of compound WX-081 (sudapyridine) when used in combination with clofazimine or clarithromycin.
Journal: Microbiology spectrum
Published: February 26, 2026
Extended vs. standard bedaquiline treatment for MDR/RR-TB: A 5-y multi-centre study on clinical outcomes and cardiac safety in China.
Journal: International journal of antimicrobial agents
Published: February 11, 2026
The clinical diagnostic value of metagenomic next-generation sequencing for patients with suspected nontuberculous mycobacterial osteoarticular infection: A national multicenter clinical cohort.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 24, 2026
Safety, tolerability, and concordance with interferon-γ release assays of a recombinant ESAT6-MPT64 skin test: a phase 1 randomized clinical trial.
Journal: Frontiers in immunology
Published: January 04, 2026
Acquired linezolid resistance in DR-TB: genotype-phenotype discordance and molecular heterogeneity in a retrospective cohort.
Journal: BMC infectious diseases
Published: November 05, 2025
Development and Validation of a Time-Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug-Resistant Tuberculosis.
Journal: Pharmacotherapy
Published: August 20, 2025
A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial.
Journal: Signal transduction and targeted therapy
Published: July 03, 2025
Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study.
Journal: Infection and drug resistance
Published: January 11, 2025
Host-directed therapy for tuberculosis.
Journal: European journal of medical research
Published: September 30, 2024
New All-Oral Short-term Regimen for Multidrug-Resistant Tuberculosis: A Semi-randomized Controlled Trial Conducted in China.
Journal: Open forum infectious diseases
Published: September 19, 2024
Last Updated: 09/26/2026